Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Mette Dahl Bendtsen"'
Autor:
Allan Riis, Cathrine Elgaard Jensen, Flemming Bro, Helle Terkildsen Maindal, Karin Dam Petersen, Mette Dahl Bendtsen, Martin Bach Jensen
Publikováno v:
Implementation Science, Vol 11, Iss 1, Pp 1-10 (2016)
Abstract Background Guidelines are often slowly adapted into clinical practice. However, actively supporting healthcare professionals in evidence-based treatment may speed up guideline implementation. Danish low back pain (LBP) guidelines focus on pr
Externí odkaz:
https://doaj.org/article/0a6669d3593342318dce6f945aff3693
Publikováno v:
Cogent Medicine, Vol 4, Iss 1 (2017)
Research has documented a high prevalence of oropharyngeal dysphagia (OD) in older patients with community-acquired pneumonia (CAP). This study investigated OD as a risk factor for long-term re-hospitalization and mortality in patients hospitalized w
Externí odkaz:
https://doaj.org/article/70dc40c45c5a48c99576f5809bf60f76
Autor:
Kaspar René Nielsen, Rudi Steffensen, Mette Dahl Bendtsen, Maria Rodrigo-Domingo, John Baech, Thure Mors Haunstrup, Kim Steve Bergkvist, Alexander Schmitz, Julie Stoeveve Boedker, Preben Johansen, Karen Dybkaeær, Martin Boeøgsted, Hans Erik Johnsen
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0139329 (2015)
BackgroundMalignant B-cell clones are affected by both acquired genetic alterations and by inherited genetic variations changing the inflammatory tumour microenvironment.MethodsWe investigated 50 inflammatory response gene polymorphisms in 355 B-cell
Externí odkaz:
https://doaj.org/article/5fca8bcbdb944f94b84bd0f4aedbec21
Autor:
Line Quist Bendtsen, Hanne Haahr, Mette Dahl Bendtsen, Thekla von dem Berge, Naveen Rathor, Torben Biester, Thomas Danne
Publikováno v:
Pediatric Diabetes
Background Fast‐acting insulin aspart (faster aspart) is a novel formulation of insulin aspart (IAsp) ensuring ultrafast absorption and effect. Aim To compare the pharmacokinetics between faster aspart and IAsp, based on free or total IAsp measurem
Autor:
Sarah Louise Dombernowsky, Mette Dahl Bendtsen, Michael Højby Rasmussen, Birgitte Bentz Damholt, Charlotte Bisgaard
Publikováno v:
Clinical Pharmacokinetics
Introduction Somapacitan is a long-acting growth hormone (GH) derivative being developed for once-weekly dosing in patients with GH deficiency (GHD). Our objective was to evaluate the impact of kidney or hepatic impairment on somapacitan exposure in
Autor:
Mikael Norman, Stine B. Bering, Abieyuwa A. Emokpae, Paola Azzurra La Verde, James S. Kemp, J. Ciaran Hutchinson, Colleen Brennan, Gianluca Lista, Francesca Castoldi, Clare M. Rees, Raksa Tupprasoot, Eleanor J. Molloy, Anna Gudmundsdottir, Elaine M. Boyle, Myriam Doyon, Francesco Cavigioli, Michael R.J. Sury, Julie Moreau, Fabio Mosca, Finn Ebbesen, Camilla Menis, Ann Cathrine Findal Støy, Samuel Julian, David Warburton, Mette Bjerre, Owen J. Arthurs, Rolf F. Maier, Per T. Sangild, Marie-France Hivert, Louise Vibede, Khashayar Vakili, Ola Didrik Saugstad, Lara Ulm, Mette Dahl Bendtsen, Arno van Heijst, Simon Eaton, Wally Carlo, Heung Bae Kim, Tore Curstedt, Jean-Luc Ardilouze, Chiara Cristiana Condello, Laura Linneman, William A. Gomes, Boris W. Kramer, Liis Toome, Julie Hoffman, Suresh Chandran, Aaron Hamvas, Rikke Wiingreen, Peter M. H. Heegaard, Xianhong Xie, Mikko Hallman, Riccardo Bonfanti, Victor Samuel Rajadurai, Guillaume Lacerte, Ludwig Gortner, Jennifer Zeitlin, Paola Roggero, Catherine Allard, Marie-Claude Battista, Alan C Fenton, Bo Mølholm Hansen, Mariana Brewer, Maria Lorella Giannì, Julie Patenaude, Mamta Fuloria, Cuong NguyenBa, Wayne Tworetzky, Francesca Taroni, Satz Mengensatzproduktion, Dean Langan, Nadia Liotto, Neena Modi, Eugene M. Dempsey, Shreyans Bengani, Ilia Bresesti, Kerstin Skovgaard, Seyed Ehsan Saffari, Gorm Greisen, Julie Ménard, Bolajoko O. Olusanya, Mimi Kim, Nigel J. Hall, Hannah Barrett, David Zurakowski, Henry L. Halliday, D W A Milligan, Colin J Morley, Thomas W. Ferkol, Colm P. Travers, Patrice Perron, Anna Orsi, Lia Mendes Pedersen, Mustafa Sulemanji, Marilyn Lacroix, Mei Chien Chua, Dominique Haumont, Steven J. Fishman, Laetitia Guillemette, Emil Vibede, Mercedes Bonet, H.J. Niemarkt, Asbjørn Hasselager, M.C. Hütten, Christian P. Speer, Christie J. Bruno, Druckerei Stückle, Gitte Zachariassen, Jia Min Wong, Anna-Karin Edstedt Bonamy, Jesper Padkær Petersen, Patrick Van Reempts, Wanyun Lin, Tine Brink Henriksen, Melissa Vega
Publikováno v:
Neonatology. 111:I-VI
Autor:
Helle Terkildsen Maindal, Mette Dahl Bendtsen, Karin Dam Petersen, Cathrine Elgaard Jensen, Martin Bach Jensen, Allan Riis, Flemming Bro
Publikováno v:
Implementation Science, Vol 11, Iss 1, Pp 1-10 (2016)
Riis, A, Jensen, C E, Bro, F, Maindal, H T, Petersen, K D, Bendtsen, M D & Jensen, M B 2016, ' A multifaceted implementation strategy versus passive implementation of low back pain guidelines in general practice : a cluster randomised controlled trial ', Wonca Europe Conference, København, Denmark, 15/06/2016-18/06/2016 . < http://www.woncaeurope2016.com/images/pdf/Book-of-Abstracts-16-06-2016.pdf >
Implementation Science : IS
Riis, A, Jensen, C E, Bro, F, Maindal, H T, Petersen, K D, Bendtsen, M D & Jensen, M B 2016, ' A multifaceted implementation strategy versus passive implementation of low back pain guidelines in general practice : a cluster randomised controlled trial ', Implementation Science, vol. 11, no. 1, 143 . https://doi.org/10.1186/s13012-016-0509-0
Riis, A, Jensen, C E, Bro, F, Maindal, H T, Petersen, K D, Bendtsen, M D & Jensen, M B 2016, ' A multifaceted implementation strategy versus passive implementation of low back pain guidelines in general practice : a cluster randomised controlled trial ', Wonca Europe Conference, København, Denmark, 15/06/2016-18/06/2016 . < http://www.woncaeurope2016.com/images/pdf/Book-of-Abstracts-16-06-2016.pdf >
Implementation Science : IS
Riis, A, Jensen, C E, Bro, F, Maindal, H T, Petersen, K D, Bendtsen, M D & Jensen, M B 2016, ' A multifaceted implementation strategy versus passive implementation of low back pain guidelines in general practice : a cluster randomised controlled trial ', Implementation Science, vol. 11, no. 1, 143 . https://doi.org/10.1186/s13012-016-0509-0
Background Guidelines are often slowly adapted into clinical practice. However, actively supporting healthcare professionals in evidence-based treatment may speed up guideline implementation. Danish low back pain (LBP) guidelines focus on primary car
Publikováno v:
Melgaard, D, Baandrup, U, Bøgsted, M, Bendtsen, M D & Kristensen, M T 2018, ' Early mobilisation of patients with community-acquired pneumonia reduce length of hospitalisation-a pilot study ', Journal of Physical Therapy Science, vol. 30, no. 7, pp. 926-932 . https://doi.org/10.1589/jpts.30.926
Journal of Physical Therapy Science
Journal of Physical Therapy Science
[Purpose] To examine if length of stay was reduced following an early mobilisation programme in patients with community-acquired pneumonia, and secondary, if such a program influenced short-term rehospitalisation and mortality rates. [Participants an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d09bb37ccdf2a0e5f54d8d639667bc9
https://vbn.aau.dk/da/publications/957f5930-8881-4912-a4d3-d6d7f83a8ace
https://vbn.aau.dk/da/publications/957f5930-8881-4912-a4d3-d6d7f83a8ace
Autor:
Brian K. Link, Eldad J. Dann, Roopesh Kansara, Maja Bech Juul, Gita Thanarajasingam, Adir Shaulov, Umar Farooq, Michael Roost Clausen, Daniel J. Smith, Andrés J.M. Ferreri, Diego Villa, Joseph M. Connors, Michael Gilbertson, Chan Yoon Cheah, Tarec Christoffer El-Galaly, Thomas Stauffer Larsen, Carrie A. Thompson, Martin Hutchings, Inger Lise Gade, John F. Seymour, Neta Goldschmidt, Teresa Calimeri, Kerry J. Savage, Jakob Werner Hansen, Grzegorz S. Nowakowski, Stephen Opat, Mette Dahl Bendtsen, Laurie H. Sehn, Staffan Holmberg, N. George Mikhaeel, Matthew J. Maurer, C. Cecchetti, Tsofia Inbar, Sabrina Cordua
Publikováno v:
El-Galaly, T C, Cheah, C Y, Bendtsen, M D, Nowakowski, G S, Kansara, R, Savage, K J, Connors, J M, Sehn, L H, Goldschmidt, N, Shaulov, A, Farooq, U, Link, B K, Ferreri, A J M, Calimeri, T, Cecchetti, C, Dann, E J, Thompson, C A, Inbar, T, Maurer, M J, Gade, I L, Juul, M B, Hansen, J W, Holmberg, S, Larsen, T S, Cordua, S, Mikhaeel, N G, Hutchings, M, Seymour, J F, Clausen, M R, Smith, D, Opat, S, Gilbertson, M, Thanarajasingam, G & Villa, D 2018, ' Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma ', European Journal of Cancer, vol. 93, pp. 57-68 . https://doi.org/10.1016/j.ejca.2018.01.073
PURPOSE: Secondary CNS involvement (SCNS) is a profoundly adverse complication of diffuse large B-cell lymphoma. Evidence from older series indicated a median overall survival (OS) < 6 months; however, data from the immunochemotherapy era are limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2b4286ba19f96fcf65520e603491c18
https://pure.au.dk/portal/da/publications/treatment-strategies-outcomes-and-prognostic-factors-in-291-patients-with-secondary-cns-involvement-by-diffuse-large-bcell-lymphoma(f3dacb05-0ad4-4eb4-86b5-eff16e7f2727).html
https://pure.au.dk/portal/da/publications/treatment-strategies-outcomes-and-prognostic-factors-in-291-patients-with-secondary-cns-involvement-by-diffuse-large-bcell-lymphoma(f3dacb05-0ad4-4eb4-86b5-eff16e7f2727).html
Autor:
Line Stensig Lynggaard, Martin Bøgsted, Anders Oest, Karen Dybkær, Ove Juul Nielsen, Gideon Ertner, Jesper Q. Thomassen, Marianne Tang Severinsen, Preben Johansen, Hans Erik Johnsen, Mette Dahl Bendtsen, Lene Sofie Granfeldt Østgård, Duruta Weber, Claudia Schöllkopf, Andreas Kiesbye Øvlisen, John Bæch, Ingolf Mølle, T B Mortensen
Publikováno v:
Øvlisen, A K, Oest, A, Bendtsen, M D, Bæch, J, Johansen, P, Lynggaard, L S, Mølle, I, Mortensen, T B, Weber, D, Ertner, G, Schöllkopf, C, Thomassen, J Q, Nielsen, O J, Østgård, L S G, Bøgsted, M, Dybkær, K, Johnsen, H E & Severinsen, M T 2018, ' Stringent or nonstringent complete remission and prognosis in acute myeloid leukemia : a Danish population-based study ', Blood Advances, vol. 2, no. 5, pp. 559-564 . https://doi.org/10.1182/bloodadvances.2017007393
Øvlisen, A K, Oest, A, Bendtsen, M D, Bæch, J, Johansen, P, Lynggaard, L S, Mølle, I, Mortensen, T B, Weber, D, Ertner, G, Schöllkopf, C, Thomassen, J Q, Nielsen, O J, Østgård, L S G, Bøgsted, M, Dybkær, K, Johnsen, H E & Severinsen, M T 2018, ' Stringent or nonstringent complete remission and prognosis in acute myeloid leukemia : a Danish population-based study ', Blood advances, vol. 2, no. 5, pp. 559-564 . https://doi.org/10.1182/bloodadvances.2017007393
Øvlisen, A K, Oest, A, Bendtsen, M D, Bæch, J, Johansen, P, Lynggaard, L S, Mølle, I, Mortensen, T B, Weber, D, Ertner, G, Schöllkopf, C, Thomassen, J Q, Nielsen, O J, Østgård, L S G, Bøgsted, M, Dybkær, K, Johnsen, H E & Severinsen, M T 2018, ' Stringent or nonstringent complete remission and prognosis in acute myeloid leukemia : a Danish population-based study ', Blood advances, vol. 2, no. 5, pp. 559-564 . https://doi.org/10.1182/bloodadvances.2017007393
Stringent complete remission (sCR) of acute myeloid leukemia is defined as normal hematopoiesis after therapy. Less sCR, including non-sCR, was introduced as insufficient blood platelet, neutrophil, or erythrocyte recovery. These latter characteristi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11cbd929b09036941930a05749baeeaa
https://findresearcher.sdu.dk:8443/ws/files/149509147/Stringent_or_nonstringent_complete_remission_and_prognosis_in_acute_myeloid_leukemia.pdf
https://findresearcher.sdu.dk:8443/ws/files/149509147/Stringent_or_nonstringent_complete_remission_and_prognosis_in_acute_myeloid_leukemia.pdf